In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...
Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: ...
PASADENA, Calif., December 15, 2025--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on December 12, ...
The pipeline of investigational therapies for hereditary angioedema (HAE) includes both novel inhibitors of known molecular targets and more ambitious gene editing-based approaches. Selected agents ...
1 PlantLab, Institute of Plant Sciences, Sant’Anna School of Advanced Studies, Pisa, Italy 2 Institute of Agricultural Biology and Biotechnology, National Research Council, Pisa, Italy RNA ...
- ARO-DIMER-PA is designed to selectively silence the expression of two genes with a single RNAi molecule using Arrowhead’s proprietary TRiM TM technology - In preclinical studies ARO-DIMER-PA ...
RNA-binding proteins (RBPs) play critical roles in numerous biological processes because they regulate RNA function by directly interacting with RNA molecules. In recent years, researchers have ...
Alan Herbert, Founder and President of InsideOutBio, discusses the significant advancements in RNA therapeutics, highlighting their role in supporting public health and their transformative potential ...
An RNA interference (RNAi) molecule that selectively targets the KRAS G12V mutation could represent a key advance in the treatment of cancer associated with this oncogenic variant. Researchers at the ...